Log in to search using one of your social media accounts:

 

Helapet introduce new, improved 20mm Vented Vial Adapter
Helapet have launched an improved 20mm Vented Vial Adapter, introducing a larger integrated air filter for rapid and reliable venting performance when drawing-up cytotoxic drugs and other hazardous medical solutions (Source: Pharmacy Europe)
Source: Pharmacy Europe - April 1, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Industry News cytotoxic drugs hazardous medical solutions helapet Latest News vented vial adapter vial venting Source Type: news

Bio Products Laboratory Receives European Approval for Coagadex ®
First-ever treatment for rare bleeding disorder ‘hereditary factor X deficiency’ approved in Europe (Source: Pharmacy Europe)
Source: Pharmacy Europe - March 31, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Haematology Patient care bleeding disorder coagadex coagulant factor X Latest News Source Type: news

Bio Products Laboratory Receives European Approval for Coagadex®
First-ever treatment for rare bleeding disorder ‘hereditary factor X deficiency’ approved in Europe (Source: Pharmacy Europe)
Source: Pharmacy Europe - March 31, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Haematology Patient care bleeding disorder coagadex coagulant factor X Latest News Source Type: news

Data presented at ECCO congress supports switching from Remicade® to biosimilar infliximab
Ten independent studies validate the growing bank of real-life clinical evidence to support switching patients from the reference infliximab (Remicade®) to biosimilar infliximab (Source: Pharmacy Europe)
Source: Pharmacy Europe - March 22, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Biosimilars Healthcare professionals Practical therapeutics Patient care Research European Crohn ’s and Colitis Organisation ibd immunogenicity infliximab Latest News remicade switching ulcerative colitis Source Type: news

LEO Pharma recieves scientific approval of Enstilar® for the treatment of psoriasis in EU
The marketing approval of Enstilar® would make it the first fixed combination topical foam treatment for people living with psoriasis vulgaris in the EU (Source: Pharmacy Europe)
Source: Pharmacy Europe - March 21, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Legislation & regulation Dermatology Patient care calcipotriol/betamethasone dipropionate enstilar fixed combination topical foam Latest News psoriasis vulgaris Source Type: news

BD receives CE mark for next generation blood separation technology
BD Vacutainer® Barricor™ Tube designed to enhance sample quality, improve laboratory efficiency and speed laboratory turnaround time (Source: Pharmacy Europe)
Source: Pharmacy Europe - March 21, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Medical Devices Haematology BD Vacutainer Barricor Tube laboratory turnaround time Latest News Source Type: news

Greater survival benefit shown in men with early and less aggressive mCRPC treated with Zytiga® plus prednisone
Janssen announced that data from a post-hoc analysis of the Phase III COU-AA-302 trial showed that ZYTIGA® plus prednisone provided an 11.8 months overall survival benefit, compared to an active control of placebo plus prednisone, in men with early and less aggressive chemotherapy-naïve metastatic castration-resistant prostate cancer (Source: Pharmacy Europe)
Source: Pharmacy Europe - March 14, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Oncology Patient care advanced prostate cancer COU-AA-302 trial European Association of Urology Latest News mCRPC Zytiga Source Type: news

SMC accepts breakthrough treatment Entresto™ for use in patients with symptomatic chronic heart failure
Sacubitril/valsartan represents a breakthrough therapeutic option for adult patients with symptomatic chronic heart failure with reduced ejection fraction (Source: Pharmacy Europe)
Source: Pharmacy Europe - March 9, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Healthcare professionals Practical therapeutics Cardiovascular medicine Patient care chronic heart failure Latest News sacubitril/valsartan scottish medicines consortium Source Type: news

Novartis’ Cosentyx® superior to Stelara in delivering lasting skin clearance for psoriasis patients
Cosentyx launched as first-line systemic indication for psoriasis in UK in 2015 and recently approved for psoriatic arthritis and ankylosing spondylitis in Europe (Source: Pharmacy Europe)
Source: Pharmacy Europe - March 9, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Dermatology Patient care Research ankylosing spondylitis Cosentyx Latest News PASI psoriatic arthritis Source Type: news

Allergan completes transfer of European MA for Ironwood’s CONSTELLA® from Almirall S.A
CONSTELLA® is the only available prescription treatment with a European Marketing Authorisation specifically for irritable bowel syndrome with constipation (Source: Pharmacy Europe)
Source: Pharmacy Europe - March 3, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Legislation & regulation Gastroenterology Patient care constella constipation IBS-C irritable bowel syndrome Latest News marketing authorisation Source Type: news

New immunotherapy trial launched to test cancer vaccine
Vaccine activates body’s own immune system to fight cancer (Source: Pharmacy Europe)
Source: Pharmacy Europe - March 2, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Oncology Patient care Research cancer vaccine immunotherapy Latest News VAPER trial Source Type: news

Prostrakan and AstraZeneca enter into agreement for rights to Moventig® in Europe
Moventig is the first once-daily, oral peripherally acting mu-opioid receptor antagonist approved in Europe for the treatment of opioid-induced constipation in adult patients who have had an inadequate response to laxative(s) (Source: Pharmacy Europe)
Source: Pharmacy Europe - March 1, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Legislation & regulation Gastroenterology Oncology Pain management Patient care Latest News laxatives moventig naloxegol oic opioid induced constipation PAMORA Source Type: news

Sobi supports The Rare Project to increase awareness about rare diseases
To highlight Rare Disease Day 2016 on 29 February, Swedish Orphan Biovitrum Ltd. (Sobi) is proud to sponsor 'The Rare Project', a project initiated by the not for profit organisation Same But Different (Source: Pharmacy Europe)
Source: Pharmacy Europe - February 24, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Paediatrics Latest News rare disease day same but different the rare project Source Type: news

New drug treatment Kyprolis® (carfilzomib) for relapsed multiple myeloma launches in the UK
In a clinical trial, relapsed patients treated with carfilzomib in combination with lenalidomide and dexamethasone lived 8.7 months longer without disease progression compared with lenalidomide and dexamethasone alone (Source: Pharmacy Europe)
Source: Pharmacy Europe - February 16, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Oncology Patient care Research ASPIRE study carfilzomib ENDEAVOR study Latest News multiple myeloma rare blood cancer Source Type: news

Spectrila® (asparaginase) by Medac received EU-wide approval for the treatment of ALL
The pharmaceutical company Medac was granted a marketing authorisation by the European Commission for Spectrila® (asparaginase), to be used as a part of an antineoplastic combination therapy to treat children and adults with acute lymphoblastic leukaemia (Source: Pharmacy Europe)
Source: Pharmacy Europe - February 11, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Medical Devices Oncology Patient care acute lymphoblastic leukaemia ALL amino acid antineoplastic combination therapy asparaginase enzyme Latest News Source Type: news

BLOG: The evolving role of a pharmacy technician
I qualified as a pharmacy technician in 2008 and decided to leave my permanent post in Somerset to locum and gain some experience of working in a few different settings (Source: Pharmacy Europe)
Source: Pharmacy Europe - February 5, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: Blogs mental health pharmacy technician self help Source Type: news

The evolving role of a pharmacy technician
I qualified as a pharmacy technician in 2008 and decided to leave my permanent post in Somerset to locum and gain some experience of working in a few different settings (Source: Pharmacy Europe)
Source: Pharmacy Europe - February 5, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: Blogs mental health pharmacy technician self help Source Type: news

EC approves Daklinza for the treatment of chronic hepatitis C patients
Bristol-Myers Squibb Company announced that the European Commission has approved Daklinza for the treatment of chronic hepatitis C (HCV) in three new patient populations (Source: Pharmacy Europe)
Source: Pharmacy Europe - February 2, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Patient care ALLY-1 ALLY-2 cirrhosis CYP3A daklinza hcv hiv-1 Latest News P-glycoprotein transporter post-liver transplant Sofosbuvir Source Type: news

Management of Alzheimer's disease in the UK
The treatment options and considerations for the ongoing management of patients with Alzheimer’s disease as well as the estimated and fragmentary cost burden on the healthcare economy in the UK are covered in this article (Source: Pharmacy Europe)
Source: Pharmacy Europe - January 29, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: Featured Articles Source Type: news

Fighting antibiotic-associated diarrhoea and antibiotic resistance
Administration of antibiotics together with probiotics can reduce the risk of developing antibiotic-associated diarrhoea and Clostridium difficile-associated diarrhoea (Source: Pharmacy Europe)
Source: Pharmacy Europe - January 29, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: Featured Articles Source Type: news

Clean up medicines with a CHAMOIS
This article outlines outcomes of the CHAMOIS team. This clinical pharmacy service for vulnerable care home residents commissioned in 2013 is now an integral part of NHS Leeds West Clinical Commissioning Group medicines optimisation teams’ work (Source: Pharmacy Europe)
Source: Pharmacy Europe - January 29, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: Featured Articles Source Type: news

Hospital pharmacists’ contribution: a perspective
Pharmacists play an important role in clinical care and the manner in which such care is delivered is evolving. A way of capturing pharmacists’ contribution to patient care when not on the ward and which might have service implications, is presented (Source: Pharmacy Europe)
Source: Pharmacy Europe - January 29, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: Featured Articles Source Type: news

Role of the clinical pharmacist in the management of CF
This article highlights the essential and varied role of clinical pharmacists as part of the cystic fibrosis (CF) multidisciplinary team (Source: Pharmacy Europe)
Source: Pharmacy Europe - January 29, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: Featured Articles Source Type: news

The Falsified Medicines Directive
This article looks at the practical implications that hospital pharmacists across Europe will need to address as we near the implementation date on 2018 for the Falsified Medicines Directive (Source: Pharmacy Europe)
Source: Pharmacy Europe - January 28, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: Featured Articles Source Type: news

EU FMD: hospital pharmacy challenges and opportunities
The forthcoming EU Falsified Medicines Directive (FMD) is mandatory for all hospital pharmacies in Europe. The three-year implementation period ahead provides an extraordinary opportunity to improve patient safety and realise efficiency savings (Source: Pharmacy Europe)
Source: Pharmacy Europe - January 28, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: Featured Articles Source Type: news

Right drug, right dose, right time, right patient!
With medication error rates anywhere between 5% and 40%, eliminating human intervention from the process of medication distribution could dramatically reduce the number of errors occurring, some of which can be serious or even life-threatening (Source: Pharmacy Europe)
Source: Pharmacy Europe - January 28, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: Featured Articles Source Type: news

Optimising immunoglobulin homecare services
As hospitals in the National Health Service face ever-increasing demands on their services from an increasingly elderly population, hospitals are induced to re-examine their models for the delivery of complex therapies (Source: Pharmacy Europe)
Source: Pharmacy Europe - January 28, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: Featured Articles Source Type: news

The nature of prescribing in the emergency department
In emergency departments in general, patient care is focused on the process that has led to the visit to the department at that particular moment. Guaranteeing patient safety and supporting the continuity care is the responsibility of healthcare staff (Source: Pharmacy Europe)
Source: Pharmacy Europe - January 28, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: Featured Articles Source Type: news

New product from Ecolab contamination control to revolutionise the transfer disinfection process
Ecolab Contamination Control, a worldwide provider of leading products and services for the control of microbial contamination in the cleanroom environment, has launched a unique product that will revolutionise the process of transfer disinfection within the pharmaceutical industry (Source: Pharmacy Europe)
Source: Pharmacy Europe - January 26, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Industry News Clean rooms and disinfectant contamination control disinfection process ecolab Latest News Source Type: news

Vectibix® and best supportive care improves overall survival in mCRC
First Phase III Vectibix trial to include a prespecified analysis of efficacy endpoints by RAS tumour status in primary analysis. Results presented at Gastrointestinal Cancers Symposium 2016 reinforce importance of RAS testing (Source: Pharmacy Europe)
Source: Pharmacy Europe - January 25, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Other conferences & symposia Gastroenterology Oncology Patient care Research amgen best supportive care exon 2 gastrointestinal cancers symposium 2016 kras Latest News Source Type: news

Breakthrough drug for heart failure now available in the UK
Novartis drug Entresto™ (sacubitril/valsartan) approved for use in adults with symptomatic chronic heart failure with reduced ejection fraction reduces mortality risk compared with current treatment according to study (Source: Pharmacy Europe)
Source: Pharmacy Europe - January 20, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Cardiovascular medicine Legislation & regulation Patient care British Society for Heart Failure chronic heart failure ejection fraction Entresto HFrEF Latest News mortality risk PARADIGM Source Type: news

Sobi's Orfadin® oral suspension granted European patent
Swedish Orphan Biovitrum AB (publ) (Sobi) announced that the European Patent Office (EPO) has decided to grant a European patent for the Orfadin® (nitisinone) oral suspension formulation (Source: Pharmacy Europe)
Source: Pharmacy Europe - January 19, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Paediatrics Practical therapeutics Legislation & regulation Hepatic disorders Nephrology Patient care hereditary tyrosinaemia type-1 HT-1 Latest News nitisinone oral suspension formulation orfadin Source Type: news

SMC issues positive advice for first ever treatment for ADPKD
JINARC® (tolvaptan) is accepted for use in Scotland for the treatment of autosomal dominant polycystic kidney disease (ADPKD) (Source: Pharmacy Europe)
Source: Pharmacy Europe - January 11, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Legislation & regulation Nephrology Patient care adpkd jinarc Latest News smc tolvaptan Source Type: news

Sobi(TM) announces commercial launch of Elocta® in first countries in Europe
Swedish Orphan Biovitrum AB announced the commercial launch of Elocta® in first countries in Europe (Source: Pharmacy Europe)
Source: Pharmacy Europe - January 11, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Haematology Patient care elocta haemophilia a Latest News recombinant human factor VIII Fc fusion protein Source Type: news

MSD’s KEYTRUDA® significantly improves survival compared to chemotherapy in NSCLC
KEYNOTE-010 published in the Lancet and to be presented at the European Society for Medical Oncology (ESMO) Asia 2015 Congress (Source: Pharmacy Europe)
Source: Pharmacy Europe - December 21, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick European Conferences and Symposia Practical therapeutics Oncology chemotherapy esmo KEYNOTE-010 keytruda Latest News non-small cell lung cancer pembrolizumab Source Type: news

European Commission approves Amgen’s IMLYGIC as first oncolytic immunotherapy in Europe
IMLYGIC is approved in the European Union specifically for early stage metastatic patients (Source: Pharmacy Europe)
Source: Pharmacy Europe - December 18, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Oncology early stage metastic patients herpes simplex type 1 virus IMLYGIC immunotherapy Latest News melanoma Source Type: news

bene-Arzneimittel receives orphan drug status for pentosan polysulphate
Pentosan polysulphate has been awarded the status of an orphan drug from the EMA for the indication of interstitial cystitis (Source: Pharmacy Europe)
Source: Pharmacy Europe - December 18, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick bladder interstitial cystitis Latest News orphan drug pentosan polysulphate Source Type: news

BGMA coordinates patient safety update with MHRA
2600 hospital pharmacies targeted with single set of clear information for patients (Source: Pharmacy Europe)
Source: Pharmacy Europe - December 10, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Association News Generic medicines Patient safety Patient care BGMA hospital pharmacy Latest News mhra Source Type: news

Takeda presents data from Phase III TOURMALINE-MM1 study for NINLARO®
NINLARO® (ixazomib) is the first and only once-weekly oral proteasome inhibitor recently approved for multiple myeloma (Source: Pharmacy Europe)
Source: Pharmacy Europe - December 7, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick ash ixazomib Latest News multiple myeloma NINLARO proteasome inhibitor TOURMALINE-MM1 trial Source Type: news

ESCMID’s EUCAST defining resistance in future antimicrobial agents
EUCAST’s unheralded, but vital work, is helping to ensure responsible use by defining common standards for antimicrobial resistance globally (Source: Pharmacy Europe)
Source: Pharmacy Europe - December 7, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Antimicrobials/AMR Medicines optimisation Harmonisation antimicrobial agents antimicrobial resistance bacteria ecdc ESCMID EUCAST Latest News minimum inhibitory concentration Source Type: news

Dompé’s rhNGF receives orphan drug designation from the EMA
The drug, discovered and developed in Italy, is being studied in patients with neurotrophic keratitis, a pathology still lacking an effective treatment that affects fewer than five out of 10,000 individuals (Source: Pharmacy Europe)
Source: Pharmacy Europe - December 3, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Legislation & regulation Specials orphan drugs Ophthalmology Research cornea eye pathology Latest News neurotrophic keratitis REPARO Phase I/II rhNGF Source Type: news

New Sandoz patient-centric inhaler now available to treat adults with COPD
Novel inhaler approved for adults with chronic obstructive pulmonary disease (COPD) (Source: Pharmacy Europe)
Source: Pharmacy Europe - November 24, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Respiratory Patient care AirFluSal copd fluticasone propionate Forspiro inhaler Latest News salmeterol Seretide Accuhaler treatment adherence Source Type: news

EC approves kyprolis® for combination use in the treatment of relapsed multiple myeloma
First irreversible proteasome inhibitor for relapsed multiple myeloma approved in the European Union (Source: Pharmacy Europe)
Source: Pharmacy Europe - November 20, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Legislation & regulation Oncology ASPIRE trial ENDEAVOR trial kyprolis Latest News protease inhibitor relapsed multiple myeloma Source Type: news

ESCMID is setting up infection control committee and conducts prescription survey
European Committee on Infection Control (EUCIC) is recruiting representatives from European countries to create national committees (Source: Pharmacy Europe)
Source: Pharmacy Europe - November 13, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Antimicrobials/AMR European Conferences and Symposia Harmonisation collaboration EAAD ESCMID ESGAP EUCAST EUCIC infection control Latest News Source Type: news

Teva launches #Laugh4Lungs social media campaign in recognition of World COPD Day 2015
Campaign uses social video to raise awareness for chronic obstructive pulmonary disease (COPD) (Source: Pharmacy Europe)
Source: Pharmacy Europe - November 12, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Respiratory Patient care copd Latest News laugh4lungs social media teva world COPD day 2015 Source Type: news

Scots asked to pledge to protect antibiotics
Scots are being asked to pledge their support to help protect antibiotics for future generations (Source: Pharmacy Europe)
Source: Pharmacy Europe - November 10, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Antimicrobials/AMR Healthcare professionals Practical therapeutics Patient care antibiotic guardian antibiotics EAAD European Antibiotic Awareness Day Latest News SAPG smc Source Type: news

PURSUIT study shows patient-reported outcomes in UC patients treated with golimumab
Further data analysis from UC CARES report on quality of life and loss of productivity (Source: Pharmacy Europe)
Source: Pharmacy Europe - November 9, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Gastroenterology Research continuous clinical response golimumab inflammatory disease Latest News PGA PURSUIT-Maintenance trial Simponi UC CARES ulcerative colitis Source Type: news

CPI part of world-class consortium to develop intelligent packaging for pharmaceuticals
The Centre for Process Innovation (CPI) is part of a UK based consortium developing technologies that will spearhead the commercialisation of intelligent pharmaceutical packaging (Source: Pharmacy Europe)
Source: Pharmacy Europe - October 30, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Industry News Technology CPI innovation intelligent pharmaceutical packaging Latest News REMEDIES project Source Type: news

World Psoriasis Day gives hope to people with psoriasis
Global awareness campaign calls for action to effect positive change for the many millions of people who live with psoriasis and psoriatic arthritis worldwide (Source: Pharmacy Europe)
Source: Pharmacy Europe - October 29, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Association News Guidelines Dermatology Patient care Policy & practice Research #iactpso #ichangepso #ihopepso IFPA Latest News wall of hope who world psoriasis day Source Type: news

Amgen receives CHMP positive opinion for IMLYGIC (TM) (talimogene laherparepvec)
IMLYGIC is first oncolytic immunotherapy to demonstrate therapeutic benefit for patients with advanced melanoma (Source: Pharmacy Europe)
Source: Pharmacy Europe - October 26, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Oncology Research advanced melanoma chmp IMLYGIC immunotherapy Latest News oncolytic immunotherapy talimogene laherparepvec Source Type: news